AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Orangekloud Technology Inc.

$1.02 +$0.30 (+41.72%)
NASDAQ · 15 Sep 2026 15:20 UTC
Previous Close
$1.04
Day Range
$0.95$1.08
Year Range
$0.62$2.76
Market Cap
5.13M
AVG Volume
179.45K
Trailing/Forward PE
-1.76/-
PEG ratio
0.03
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Revenue (SGD)
02M4M6M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT Revenue (SGD) by quarter
PeriodRevenue (SGD)
25 Q43.13M
25 Q22.45M
24 Q41.95M
24 Q22.09M
23 Q43.2M
23 Q22.89M
22 Q44.03M
22 Q23.12M
Net Income (SGD)
-7.5M-5M-2.5M02.5M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT Net Income (SGD) by quarter
PeriodNet Income (SGD)
25 Q4-907.21K
25 Q2-3.43M
24 Q4-7.31M
24 Q2-1.34M
23 Q4-400.73K
23 Q2-906.97K
22 Q41.55M
22 Q2436.59K
Operating Income (SGD)
-7.5M-5M-2.5M02.5M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT Operating Income (SGD) by quarter
PeriodOperating Income (SGD)
25 Q4-3.52M
25 Q2-3.79M
24 Q4-7.41M
24 Q2-1.27M
23 Q4-416.12K
23 Q2-260.73K
22 Q41.53M
22 Q2280.45K
EBITDA (SGD)
-7.5M-5M-2.5M02.5M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT EBITDA (SGD) by quarter
PeriodEBITDA (SGD)
25 Q4-3.26M
25 Q2-3.42M
24 Q4-7.33M
24 Q2-1.19M
23 Q4-1.07M
23 Q2-116.43K
22 Q41.64M
22 Q2589.49K
Cash Flows (SGD)
-6M-4M-2M02M22 Q222 Q423 Q223 Q424 Q224 Q425 Q4
ORKT Cash Flows (SGD) by quarter
PeriodCash Flows (SGD)
25 Q4-4.94M
24 Q40
24 Q20
23 Q4-617.68K
23 Q2-408.71K
22 Q4953.04K
22 Q2-148.3K
EPS (SGD)
-1.5-1-0.500.522 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT EPS (SGD) by quarter
PeriodEPS (SGD)
25 Q4-0.15
25 Q2-0.59
24 Q4-1.28
24 Q2-0.26
23 Q4-0.08
23 Q2-0.18
22 Q40.31
22 Q20.09
Expenses (SGD)
02.5M5M7.5M10MR&DSG&ACapex22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT Expenses (SGD) by quarter
PeriodExpenses (SGD)
25 Q45.24M
25 Q24.5M
24 Q48.48M
24 Q21.71M
23 Q41.97M
23 Q21.96M
22 Q41.22M
22 Q21.45M
Cash & Debt (SGD)
02.5M5M7.5M10MCashLong Term DebtShort Term Debt22 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT Cash & Debt (SGD) by quarter
PeriodCash & Debt (SGD)
25 Q42.99M
25 Q25.57M
24 Q48.17M
24 Q2724.32K
23 Q41.07M
23 Q21.69M
22 Q42M
Debt ratios
-0.2500.250.50.75123 Q424 Q224 Q425 Q225 Q4
ORKT Debt ratios by quarter
PeriodDebt ratios
25 Q40.09
25 Q20.4
24 Q40.79
24 Q20.05
23 Q4-0.19
Margins
0%20%40%60%80%22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT Margins by quarter
PeriodMargins
25 Q442.79%
25 Q229.11%
24 Q425.11%
24 Q226.94%
23 Q454.29%
23 Q239.3%
22 Q470.11%
22 Q244.18%
Return on Capital
-200%-100%0%100%22 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT Return on Capital by quarter
PeriodReturn on Capital
25 Q4-10.66%
25 Q2-36.88%
24 Q4-53.89%
24 Q2-188.24%
23 Q4-19.11%
23 Q2-36.73%
22 Q446.11%
Shares Outstanding
02M4M6M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT Shares Outstanding by quarter
PeriodShares Outstanding
25 Q45.84M
25 Q25.84M
24 Q45.7M
24 Q25M
23 Q45M
23 Q25M
22 Q45M
22 Q25M
Book Value Per Share (SGD)
012322 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT Book Value Per Share (SGD) by quarter
PeriodBook Value Per Share (SGD)
25 Q41.46
25 Q21.59
24 Q42.38
24 Q20.14
23 Q40.42
23 Q20.49
22 Q40.67
Total Assets (SGD)
05M10M15M20M22 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ORKT Total Assets (SGD) by quarter
PeriodTotal Assets (SGD)
25 Q411.85M
25 Q211.17M
24 Q416.02M
24 Q23.03M
23 Q44.22M
23 Q25.16M
22 Q46.73M
Employee Count
02040608020242025
ORKT Employee Count by quarter
PeriodEmployee Count
202564
202461
PE Ratio
160180200220med 210.64Jul 24Aug 24Aug 24Aug 24Aug 24
ORKT PE Ratio by quarter
PeriodPE Ratio
Aug 24190.86
Aug 24177.98
Aug 24214.16
Aug 24210.64
Jul 24218.32
Free Cash Flow Yield
-0.8%-0.6%-0.4%-0.2%-0%med -0.24%Aug 24Oct 24Dec 24Feb 25Apr 25Jun 25Aug 25
ORKT Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Aug 25-0.39%
Aug 25-0.39%
Aug 25-0.36%
Aug 25-0.4%
Jul 25-0.36%
Jul 25-0.4%
Jul 25-0.36%
Jul 25-0.49%
Jun 25-0.58%
Jun 25-0.51%
Jun 25-0.57%
Jun 25-0.53%
May 25-0.62%
May 25-0.61%
May 25-0.59%
May 25-0.6%
May 25-0.56%
Apr 25-0.45%
Apr 25-0.5%
Apr 25-0.43%
Apr 25-0.41%
Mar 25-0.35%
Mar 25-0.36%
Mar 25-0.36%
Mar 25-0.29%
Feb 25-0.27%
Feb 25-0.25%
Feb 25-0.22%
Feb 25-0.21%
Jan 25-0.16%
Jan 25-0.39%
Jan 25-0.24%
Jan 25-0.08%
Jan 25-0.08%
Dec 24-0.1%
Dec 24-0.14%
Dec 24-0.09%
Dec 24-0.09%
Nov 24-0.09%
Nov 24-0.09%
Nov 24-0.1%
Nov 24-0.08%
Nov 24-0.15%
Oct 24-0.16%
Oct 24-0.04%
Oct 24-0.04%
Oct 24-0.06%
Sep 24-0.06%
Sep 24-0.06%
Sep 24-0.06%
Sep 24-0.06%
Aug 24-0.06%
Aug 24-0.17%
Aug 24-0.18%
Aug 24-0.15%
Aug 24-0.15%
Jul 24-0.15%
Price to Sales
02468med 1.03Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ORKT Price to Sales by quarter
PeriodPrice to Sales
Sep 260.8
Sep 260.78
Sep 260.77
Aug 260.75
Aug 260.78
Aug 260.78
Aug 260.78
Jul 260.75
Jul 260.84
Jul 260.82
Jul 260.85
Jul 260.76
Jun 260.86
Jun 260.99
Jun 261.03
Jun 260.94
May 260.9
May 260.8
May 260.79
May 260.8
May 260.8
Apr 260.83
Apr 260.81
Apr 260.76
Apr 260.79
Mar 260.79
Mar 260.72
Mar 260.78
Mar 260.8
Feb 260.92
Feb 260.86
Feb 260.9
Feb 260.8
Jan 260.98
Jan 260.6
Jan 260.54
Jan 260.59
Jan 260.55
Dec 250.63
Dec 250.71
Dec 250.86
Dec 250.72
Nov 250.74
Nov 250.71
Nov 250.83
Nov 250.86
Oct 251.06
Oct 251.21
Oct 251.2
Oct 251.45
Oct 251.42
Sep 251.65
Sep 251.72
Sep 251.64
Sep 251.54
Aug 251.97
Aug 251.55
Aug 251.55
Aug 251.68
Aug 251.5
Jul 251.67
Jul 251.51
Jul 251.66
Jul 251.23
Jun 251.03
Jun 251.18
Jun 251.05
Jun 251.12
May 250.97
May 250.99
May 251.02
May 251
May 251.08
Apr 251.34
Apr 251.2
Apr 251.4
Apr 251.46
Mar 251.73
Mar 251.68
Mar 251.68
Mar 252.05
Feb 252.21
Feb 252.41
Feb 252.7
Feb 252.84
Jan 253.85
Jan 251.52
Jan 252.51
Jan 257.5
Jan 257.18
Dec 245.8
Dec 244.33
Dec 246.85
Dec 246.4
Nov 246.86
Nov 246.81
Nov 246.22
Nov 247.77
Nov 243.97
Oct 243.85
EV/EBITDA
110120130140150med 137.34Jul 24Aug 24Aug 24Aug 24Aug 24
ORKT EV/EBITDA by quarter
PeriodEV/EBITDA
Aug 24124.43
Aug 24116.02
Aug 24139.64
Aug 24137.34
Jul 24142.35
Price/Operating Cashflow
400425450475500med 480.71Jul 24Aug 24Aug 24Aug 24Aug 24
ORKT Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Aug 24435.56
Aug 24406.16
Aug 24488.74
Aug 24480.71
Jul 24498.22
Price to Book
050100150med 1.64Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ORKT Price to Book by quarter
PeriodPrice to Book
Sep 260.9
Sep 260.88
Sep 260.87
Aug 260.85
Aug 260.88
Aug 260.89
Aug 260.88
Jul 260.85
Jul 260.95
Jul 260.92
Jul 260.96
Jul 260.85
Jun 260.97
Jun 261.12
Jun 261.16
Jun 261.06
May 261.02
May 260.9
May 260.9
May 260.9
May 260.91
Apr 260.59
Apr 260.58
Apr 260.54
Apr 260.56
Mar 260.56
Mar 260.51
Mar 260.56
Mar 260.57
Feb 260.66
Feb 260.62
Feb 260.64
Feb 260.57
Jan 260.7
Jan 260.43
Jan 260.39
Jan 260.42
Jan 260.39
Dec 250.45
Dec 250.5
Dec 250.61
Dec 250.51
Nov 250.53
Nov 250.51
Nov 250.6
Nov 250.62
Oct 250.76
Oct 251.38
Oct 251.37
Oct 251.65
Oct 251.62
Sep 251.88
Sep 251.97
Sep 251.88
Sep 251.76
Aug 252.26
Aug 2526.51
Aug 2526.64
Aug 2528.85
Aug 2525.68
Jul 2528.57
Jul 2525.97
Jul 2528.38
Jul 2521.11
Jun 2517.72
Jun 2520.22
Jun 2517.98
Jun 2519.26
May 2516.66
May 2516.94
May 2517.51
May 2517.21
May 2518.48
Apr 2522.88
Apr 2520.6
Apr 2523.95
Apr 2525.05
Mar 2529.64
Mar 2528.87
Mar 2528.82
Mar 2535.11
Feb 2537.92
Feb 2541.26
Feb 2546.22
Feb 2548.67
Jan 2565.96
Jan 2526.06
Jan 2543.05
Jan 25128.54
Jan 25123.04
Dec 2499.43
Dec 2474.14
Dec 24117.34
Dec 24109.61
Nov 24117.61
Nov 24116.7
Nov 24106.58
Nov 24133.18
Nov 2468.09
Oct 2466
Orangekloud Technology Inc.
ORKT
Stockpicker

Video analysis: ORKT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ORKT

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.